Home › Stocks › LIPO

LIPO — LIPELLA PHARMACEUTICALS INC

Reported value held$352.27K
Funds holding (latest)13
Sector—

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

LIPO (LIPELLA PHARMACEUTICALS INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 13 funds have reported positions historically, with the sum of their latest reported stakes valued at $352.27K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.

Major shareholders of LIPELLA PHARMACEUTICALS INC (LIPO) include SABBY MANAGEMENT, LLC, Virtu Financial LLC, Vanguard Group, ranked by reported 13F value among the 13 institutional holders on this page.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q1 2025 3 2.84K $7.13K +0.0%
Q4 2024 3 13.44K $41.40K -85.1%
Q3 2024 5 84.80K $39.71K -1.6%
Q2 2024 7 630.29K $284.04K +78.9%
Q1 2024 9 379.80K $260.08K -5.9%
Q4 2023 7 370.01K $275.33M +6.5%
Q3 2023 4 39.64K $59.46K +211.1%
Q2 2023 1 9 $19 +12.5%

Over the 8 quarters shown, institutional share counts increased 31456% in aggregate (Q2 2023 → Q1 2025); the largest single-quarter swing was Q3 2023 (+211.1%).

Top Institutional Holders (Q1 2025) — 3 funds

FundSharesValuePortfolio WeightChange
Tower Research Capital LLC (TRC) 2.71K $6.80K 0.00% New
MAI Capital Management 125 $314 0.00% Hold
Bank of America Corp 7 $18 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q4 2024 — 3 funds

FundSharesValuePortfolio WeightChange
Virtu Financial LLC 13.31K $41.00K 0.00% New
MAI Capital Management 125 $382 0.00% New
Bank of America Corp 7 $21 0.00% Reduce

Q3 2024 — 5 funds

FundSharesValuePortfolio WeightChange
Vanguard Group 34.52K $16.29K 0.00% Hold
Geode Capital Management 24.91K $11.76K 0.00% Reduce
HRT FINANCIAL LP 17.62K $8.00K 0.00% New
Tower Research Capital LLC (TRC) 7.69K $3.63K 0.00% Hold
Bank of America Corp 47 $22 0.00% Add

Q2 2024 — 7 funds

FundSharesValuePortfolio WeightChange
SABBY MANAGEMENT, LLC 540.25K $243.11K 0.91% Add
Vanguard Group 34.52K $15.53K 0.00% Hold
Geode Capital Management 26.00K $12.11K 0.00% Reduce
Two Sigma Investments 12.98K $5.84K 0.00% Reduce
UBS Group AG 8.78K $3.95K 0.00% New
Tower Research Capital LLC (TRC) 7.72K $3.47K 0.00% Hold
Bank of America Corp 46 $21 0.00% New

Q1 2024 — 9 funds

FundSharesValuePortfolio WeightChange
SABBY MANAGEMENT, LLC 249.90K $171.18K 0.40% Reduce
Geode Capital Management 42.09K $28.83K 0.00% Hold
Vanguard Group 34.52K $23.65K 0.00% Hold
Citadel Advisors 22.07K $15.12K 0.00% New
Two Sigma Investments 13.08K $8.96K 0.00% Reduce
HRT FINANCIAL LP 10.33K $7.00K 0.00% New
Tower Research Capital LLC (TRC) 7.71K $5.28K 0.00% Add
Fidelity Management & Research (FMR) 65 $45 0.00% New
Wells Fargo & Co 30 $21 0.00% Add

Q4 2023 — 7 funds

FundSharesValuePortfolio WeightChange
SABBY MANAGEMENT, LLC 269.83K $275.23M 2.19% New
Geode Capital Management 42.09K $42.93K 0.00% New
Vanguard Group 34.52K $35.21K 0.00% Hold
Two Sigma Investments 15.87K $16.18K 0.00% New
Tower Research Capital LLC (TRC) 6.92K $7.06K 0.00% Add
UBS Group AG 761 $776 0.00% Add
Wells Fargo & Co 29 $30 0.00% Add

New Positions (latest)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 13 funds)

FundQ1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Tower Research Capital LLC (TRC) 2.71K — 7.69K 7.72K 7.71K 6.92K 4.92K — —
MAI Capital Management 125 125 — — — — — — —
Bank of America Corp 7 7 47 46 — — — — —
SABBY MANAGEMENT, LLC — — — 540.25K 249.90K 269.83K — — —
Vanguard Group — — 34.52K 34.52K 34.52K 34.52K 34.52K — —
Geode Capital Management — — 24.91K 26.00K 42.09K 42.09K — — —
Virtu Financial LLC — 13.31K — — — — — — —
Two Sigma Investments — — — 12.98K 13.08K 15.87K — — —
Citadel Advisors — — — — 22.07K — — — —
HRT FINANCIAL LP — — 17.62K — 10.33K — — — —
UBS Group AG — — — 8.78K — 761 172 — —
Fidelity Management & Research (FMR) — — — — 65 — — — —
Wells Fargo & Co — — — — 30 29 28 9 8

Download holders (CSV)

FAQ

Which funds hold LIPO?

13 funds have reported positions in LIPO across five years of 13F filings; the sum of their latest reported stakes is $352.27K.

Who are the top institutional holders of LIPO?

The largest 13F holders are SABBY MANAGEMENT, LLC, Virtu Financial LLC, Vanguard Group, Citadel Advisors, Geode Capital Management; the top 25 are ranked at the top of this page.

Who are the major shareholders of LIPELLA PHARMACEUTICALS INC?

The major shareholders of LIPELLA PHARMACEUTICALS INC (LIPO) by reported 13F value are SABBY MANAGEMENT, LLC, Virtu Financial LLC, Vanguard Group, Citadel Advisors, Geode Capital Management, among 13 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own LIPO" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/LIPO/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →